Home > Insider Trading > Filing (0001708138-20-000082)

Filing Details

Accession Number:: 0001708138-20-000082
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-07-02 16:02:20
Reporting Period:: 2020-07-01

Accepted Time:: 2020-07-02 16:02:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc.	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1174475	S Michael Brown	777 Old Saw Mill River Road Tarrytown NY 10591		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-07-01	3,613	$413.33	4,256	No	4	M	Direct
Common Stock	Disposition	2020-07-01	100	$601.70	4,156	No	4	S	Direct
Common Stock	Disposition	2020-07-01	627	$603.39	3,529	No	4	S	Direct
Common Stock	Disposition	2020-07-01	960	$604.82	2,569	No	4	S	Direct
Common Stock	Disposition	2020-07-01	401	$605.78	2,168	No	4	S	Direct
Common Stock	Disposition	2020-07-01	319	$608.59	1,849	No	4	S	Direct
Common Stock	Disposition	2020-07-01	200	$609.51	1,649	No	4	S	Direct
Common Stock	Disposition	2020-07-01	100	$615.23	1,549	No	4	S	Direct
Common Stock	Disposition	2020-07-01	200	$616.49	1,349	No	4	S	Direct
Common Stock	Disposition	2020-07-01	100	$623.07	1,249	No	4	S	Direct
Common Stock	Disposition	2020-07-01	6	$624.19	1,243	No	4	S	Direct
Common Stock	Disposition	2020-07-01	200	$607.35	1,043	No	4	S	Direct
Common Stock	Disposition	2020-07-01	400	$612.29	643	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-07-01	3,613	$0.00	3,613	$413.33

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,225		2025-01-02	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,000	Indirect	by SLAT
Common Stock	11,349	Indirect	by Trust

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 627 shares of Company stock on July 1, 2020 at prices ranging from $602.95 to $603.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2020 at each separate price.
Represents volume-weighted average price of sales of 960 shares of Company stock on July 1, 2020 at prices ranging from $604.16 to $605.03. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2020 at each separate price.
Represents volume-weighted average price of sales of 401 shares of Company stock on July 1, 2020 at prices ranging from $605.25 to $606.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2020 at each separate price.
Represents volume-weighted average price of sales of 319 shares of Company stock on July 1, 2020 at prices ranging from $608.14 to $609.12. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2020 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on July 1, 2020 at prices ranging from $609.22 to $609.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2020 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on July 1, 2020 at prices ranging from $607.10 to $607.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2020 at each separate price.
Represents volume-weighted average price of sales of 400 shares of Company stock on July 1, 2020 at prices ranging from $612.21 to $612.35. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2020 at each separate price.
These shares are held in a trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.